Cargando...
High-resolution crystal structure of the therapeutic antibody pembrolizumab bound to the human PD-1
Pembrolizumab is an FDA-approved therapeutic antibody that targets the programmed cell death-1 (PD-1) to block the immune checkpoint pathway for the treatment of various types of cancer. It receives remarkable attention due to the high degree of efficacy. Very recently, the crystal structure of the...
Guardado en:
| Publicado en: | Sci Rep |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Nature Publishing Group
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5062252/ https://ncbi.nlm.nih.gov/pubmed/27734966 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep35297 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|